Hairgrow

Hairgrow is a topical minoxidil product marketed in the European Union. It contains the potassium‑channel opener minoxidil, a hair‑growth stimulant classified under ATC code D05AX02. The formulation is applied to the scalp to address hair thinning. While the exact concentration is not disclosed, Hairgrow follows the typical topical delivery used for androgenic alopecia and other forms of hair loss. It is intended for regular use as directed by a healthcare professional.

Hairgrow is indicated for the topical treatment of pattern hair loss and other non‑scarring alopecias, where it may help stimulate follicular activity and prolong the growth phase of hair.

- Androgenic (pattern) alopecia in men. - Androgenic (pattern) alopecia in women. - Diffuse hair thinning not caused by scarring. - Hair loss associated with hormonal changes. - Maintenance of newly regrown hair after successful therapy. - Post‑operative hair shedding where regrowth is desired. - Adjunct to other hair‑restoration procedures such as microneedling. - Use in combination with nutritional support for overall scalp health.

Topical minoxidil may cause local and systemic effects; most are mild and reversible, while rare reactions require medical attention.

Common: - Scalp irritation, itching or redness at the application site. - Dryness or flaking of the scalp. - Unwanted facial hair growth (hypertrichosis) near the treated area. - Temporary increase in hair shedding during the first weeks of use. - Contact dermatitis with rash or blistering. - Burning sensation on the scalp after application.

Serious: - Rapid heart rate (tachycardia) or palpitations. - Severe dizziness or fainting. - Swelling of hands, feet, or face (edema). - Sudden weight gain or fluid retention. - Chest pain or shortness of breath. - Severe allergic reaction with swelling of lips or tongue.

When using Hairgrow, several precautions should be observed to minimize risks and ensure optimal results.

- Apply only to dry scalp and avoid contact with eyes or mucous membranes. - Do not use on irritated, infected, or sunburned skin. - Limit application to the recommended area; excessive use does not improve outcomes. - Discontinue use and seek medical advice if severe irritation or systemic symptoms develop. - Pregnant or nursing individuals should consult a healthcare professional before starting treatment. - Store the product at room temperature, away from direct sunlight and out of reach of children.

Hairgrow may interact with certain medications or substances; awareness of these interactions helps avoid adverse effects.

Avoid: - Concurrent use of oral vasodilators or antihypertensive agents without medical supervision. - Applying other topical scalp medications (e.g., corticosteroids) to the same area without guidance. - Use with other potassium‑channel openers; increased systemic absorption may occur.

Use with caution: - Beta‑blockers or other cardiovascular drugs; monitor blood pressure and heart rate. - Hair dyes or chemical treatments; allow the scalp to dry before applying Hairgrow. - Supplements that affect blood flow, such as ginkgo biloba; discuss with a clinician.